Circumvention of multi-drug resistance in human kidney and kidney carcinomain vitro (Q68296259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673084%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Circumvention of multi-drug resistance in human kidney and kidney carcinoma in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673084%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Circumvention of multi-drug resistance in human kidney and kidney carcinomain vitro (English)

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

25 October 2022

main subject

multiple drug resistance

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

25 October 2022

author name string

M. Volm

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673084

25 October 2022

E. W. Pommerenke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673084

25 October 2022

T. Efferth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673084

25 October 2022

H. Löhrke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673084

25 October 2022

J. Mattern

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673084

25 October 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673084%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

15 May 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1673084

full work available at URL

25 October 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

25 October 2022

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

25 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673084%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673084%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673084%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

2484-2489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673084%20AND%20SRC:MED&resulttype=core&format=json

The multidrug resistance phenotype

23 September 2019

cites work

2

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Multidrug resistance: molecular biology and clinical relevance.

25 October 2022

3

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells

25 October 2022

4

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Amplification and expression of genes associated with multidrug resistance in mammalian cells.

25 October 2022

5

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells

25 October 2022

6

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein.

25 October 2022

10

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins

25 October 2022

11

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

25 October 2022

12

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

25 October 2022

13

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Expression of a multidrug resistance gene in human cancers

25 October 2022

14

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

P-glycoprotein in human sarcoma: evidence for multidrug resistance

25 October 2022

15

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Detection of P-glycoprotein in human leukemias using monoclonal antibodies.

25 October 2022

17

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Detection of drug resistance and P-glycoprotein in human renal cell carcinomas.

25 October 2022

18

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

P-glycoprotein expression in treated and untreated human breast cancer

25 October 2022

19

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts

25 October 2022

20

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

25 October 2022

21

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients

25 October 2022

22

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

25 October 2022

23

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Occurrence of a multidrug-resistant phenotype in human lung xenografts

25 October 2022

24

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants

25 October 2022

27

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance

25 October 2022

28

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

25 October 2022

30

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

25 October 2022

31

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Expression of a multidrug-resistance gene in human tumors and tissues

25 October 2022

32

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method

25 October 2022

33

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy

25 October 2022

35

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

In vitro short-term test to determine the resistance of human tumors to chemotherapy: Group for Sensitivity Testing of Tumors (KSST)

25 October 2022

36

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with reserpine

25 October 2022

40

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells

25 October 2022

41

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Journal of the National Cancer Institute

25 October 2022

42

76

947

Yamaguchi

1986

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma

25 October 2022

43

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

25 October 2022

Cancer Treatment Reports

44

66

121

Chlebowski

1982

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A.

25 October 2022

45

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test

25 October 2022

47

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Clinical value of in vitro drug sensitivity testing based on short-term effects on DNA and RNA metabolism in ovarian cancer

25 October 2022

48

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

In vitro chemosensitivity testing in the treatment of ovarian carcinoma

25 October 2022

49

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

Addition of verapamil to overcome drug resistance in multiple myeloma: preliminary clinical observations in 10 patients.

25 October 2022

50

1 reference

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2484::AID-CNCR2820671016%3E3.0.CO;2-I

25 October 2022

Identifiers

10.1002/1097-0142(19910515)67:10<2484::AID-CNCR2820671016>3.0.CO;2-I

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1673084%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference